Showing 14,641 - 14,660 results of 47,188 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 1.31s Refine Results
  1. 14641

    Figure 1 raw data by Urban Bezeljak (8372241)

    Published 2020
    “…We constructed a model of the minimal Rab5 activation network based on the known literature (9–11, 21, 53). …”
  2. 14642
  3. 14643

    Data Sheet 5_Beyond salt tolerance: SOS1-13’s pivotal role in regulating the immune response to Fusarium oxysporum in Solanum phureja.docx by Liqin Liang (652560)

    Published 2025
    “…</p>Results<p>StSOS1-13-overexpressed Arabidopsis differed from WT plants in multiple aspects post-FOX infection. …”
  4. 14644
  5. 14645
  6. 14646
  7. 14647

    A new method of recording from the giant fiber of <i>Drosophila melanogaster</i> shows that the strength of its auditory inputs remains constant with age by Jonathan M. Blagburn (8259648)

    Published 2020
    “…Subsequently JON sensitivity decreased with age, being approximately half as sensitive at 20 d and one-third as sensitive at 50 d, as compared to 10 d. …”
  8. 14648
  9. 14649

    Table5_A-Kinase Anchor Protein 1 deficiency causes mitochondrial dysfunction in mouse model of hyperoxia induced acute lung injury.xlsx by Ramani Soundararajan (651915)

    Published 2022
    “…Wt mice exposed to hyperoxia.</p><p>Results: Transcriptome analysis of Akap1<sup>−/−</sup> exposed to hyperoxia reveals increases in transcripts encoding electron transport chain (ETC) and tricarboxylic acid cycle (TCA) proteins. …”
  10. 14650
  11. 14651

    Presentation 1_Case Report: Full recovery in severe ParvovirusB19 myocarditis with DCM phenotype: the impact of rASD and PAB.pptx by T. Logeswaran (21495341)

    Published 2025
    “…The pressure gradient across the PAB ranged from 40 to 45 mmHg, and LVEDD decreased to a mean z-score of +3.5. Within three to six months, LVEDD normalized, and LV-EF increased to a mean of 63% (range: 57%–68%). …”
  12. 14652

    RecA data. by John L. Kulp III (4389241)

    Published 2017
    “…The steady state rate of creation of the fluorescence is plotted on the y-axis in relative fluorescence units (RFU). The addition of a RecA inhibitor decreases the rate of production of RFUs in a concentration dependent manner. 6-Hydroxydopamine inhibits RecA with an IC<sub>50</sub> of 23 uM. …”
  13. 14653

    Data_Sheet_1_Independent effect of body mass index variation on amyloid-β positivity.docx by Sung Hoon Kang (2258038)

    Published 2022
    “…</p>Methods<p>We retrospectively recruited 1,035 non-demented participants ≥50 years of age who underwent Aβ PET and had at least three BMI measurements in the memory clinic at Samsung Medical Center. …”
  14. 14654
  15. 14655
  16. 14656

    Foxf1 promotes expression of a Wnt signaling reporter. by Ugo Coppola (3524945)

    Published 2024
    “…<i>Xla-Sia</i>:<i>GFP</i> embryos at 34 hpf. (<b>A’-C’</b>) <i>7xTcf</i>.<i>Xla-Sia</i>:<i>GFP</i> (green), (<b>A”-C”</b>) Mhc (red), and (<b>A”’-C”’</b>) Amhc (blue). …”
  17. 14657

    Functional analyses of ARHGAP11A-knockdown HCT116 human colon cancer cells. by Yoshinori Kagawa (503599)

    Published 2013
    “…(I) <i>In vivo</i> siRNA treatment of HCT116 tumors. Control HCT116 cells (5.0×10<sup>6</sup>) were implanted into NOD/SCID mice, and 1 week later were treated with PBS (<i>black filled</i> circles), atelocollagen (<i>black filled</i> triangles), scrambled control siRNA plus atelocollagen (<i>black filled</i> squares), or two siRNAs (#1 and #2) against ARHGAP11A plus atelocollagen (<i>red open</i> circles and squares, respectively). …”
  18. 14658

    Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2019
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  19. 14659

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2019
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  20. 14660

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2022
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”